NEVIRAPINE Side Effects

7013141-X | Abdominal Pain, Hepatotoxicity
on Sep 13, 2010 Female patient from , 45 years of age, weighting 121.3 lb, was diagnosed with hiv infection (What is hiv infection?), tuberculosis (What is tuberculosis?), prophylaxis and was treated with Nevirapine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), hepatotoxicity. Nevirapine dosage: 200 Mg. During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), RIFAMPIN (View Rifampin Review and Rifampin Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), COTRIM (View Cotrim Review and Cotrim Label ).

7013138-X | Hepatotoxicity, Rash Maculo-papular, Vomiting
Patient was taking Nevirapine (View Usage). Patient had the following side effects: hepatotoxicity, rash maculo-papular, vomiting on Sep 13, 2010 from Additional patient health information: Female patient , 33 years of age, weighting 114.6 lb, was diagnosed with hiv infection (What is hiv infection?), pulmonary tuberculosis, prophylaxis and. Nevirapine dosage: 200 Mg. During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), COTRIM (View Cotrim Review and Cotrim Label ).

7012866-X | Hepatotoxicity, Jaundice, Vomiting
Adverse event was reported on Sep 13, 2010 by a Female patient taking Nevirapine (View Usage) (Dosage: 200 Mg) was diagnosed with hiv infection (What is hiv infection?), tuberculosis (What is tuberculosis?), prophylaxis and. Location: , 27 years of age, weighting 99.21 lb, After Nevirapine was administered, patient had the following side effects: hepatotoxicity, jaundice (What is jaundice?), vomiting. During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), RIFAMPIN (View Rifampin Review and Rifampin Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), COTRIM (View Cotrim Review and Cotrim Label ).

6920019-6 | Bleeding Varicose Vein, Gastric Varices, Portal Hypertension, Portal Hypertensive Gastropathy, Varices Oesophageal
on Aug 19, 2009 Female patient from , 43 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Nevirapine (View Usage). Patient experienced the following unwanted or unexpected effects: bleeding varicose vein, gastric varices, portal hypertension, portal hypertensive gastropathy, varices oesophageal. Nevirapine dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), INDINAVIR (View Indinavir Review and Indinavir Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ). Patient was hospitalized.


6920016-0 | Portal Hypertension, Portal Hypertensive Gastropathy, Varices Oesophageal
on Aug 19, 2009 Male patient from , 40 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Nevirapine (View Usage). Patient had the following side effects: portal hypertension, portal hypertensive gastropathy, varices oesophageal. Nevirapine dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ). Patient was hospitalized.

6920015-9 | Portal Hypertension, Portal Hypertensive Gastropathy, Varices Oesophageal
Patient was taking Nevirapine (View Usage). After Nevirapine was administered, patient had the following side effects: portal hypertension, portal hypertensive gastropathy, varices oesophageal on Aug 19, 2009 from Additional patient health information: Female patient , 48 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Nevirapine dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ). Patient was hospitalized.

6920014-7 | Oesophageal Varices Haemorrhage, Portal Hypertension, Portal Hypertensive Gastropathy, Varices Oesophageal
Adverse event was reported on Aug 19, 2009 by a Male patient taking Nevirapine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: , 57 years of age, Patient experienced the following unwanted or unexpected effects: oesophageal varices haemorrhage, portal hypertension, portal hypertensive gastropathy, varices oesophageal. During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), INDINAVIR (View Indinavir Review and Indinavir Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ). Patient was hospitalized.

6919834-4 | Bleeding Varicose Vein, Gastric Varices, Portal Hypertension, Portal Hypertensive Gastropathy, Varices Oesophageal
on Aug 19, 2009 Female patient from , 36 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Nevirapine (View Usage). Patient had the following side effects: bleeding varicose vein, gastric varices, portal hypertension, portal hypertensive gastropathy, varices oesophageal. Nevirapine dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), INDINAVIR (View Indinavir Review and Indinavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized.

6919779-X | Ascites, Portal Hypertension, Portal Hypertensive Gastropathy, Portal Vein Thrombosis, Varices Oesophageal
on Aug 19, 2009 Female patient from , 46 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Nevirapine (View Usage). After Nevirapine was administered, patient had the following side effects: ascites, portal hypertension, portal hypertensive gastropathy, portal vein thrombosis, varices oesophageal. Nevirapine dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), INDINAVIR (View Indinavir Review and Indinavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ). Patient was hospitalized.

6916572-9 |
Patient was taking Nevirapine (View Usage). on Jul 30, 2010 from Additional patient health information: Female patient , 21 years of age, was diagnosed with prophylaxis, human immunodeficiency virus transmission and. Nevirapine dosage: 400 Mg. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6916569-9 |
Adverse event was reported on Jul 30, 2010 by a Female patient taking Nevirapine (View Usage) (Dosage: 400 Mg) was diagnosed with prophylaxis, human immunodeficiency virus transmission and. Location: , 33 years of age, . During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6916567-5 | Pre-eclampsia
on Jul 30, 2010 Female patient from , 33 years of age, was diagnosed with prophylaxis, human immunodeficiency virus transmission and was treated with Nevirapine (View Usage). After Nevirapine was administered, patient had the following side effects: pre-eclampsia. Nevirapine dosage: 400 Mg. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6916566-3 |
on Jul 30, 2010 Female patient from , 38 years of age, was diagnosed with prophylaxis, human immunodeficiency virus transmission and was treated with Nevirapine (View Usage). . Nevirapine dosage: 400 Mg. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6916565-1 | Pre-eclampsia
Patient was taking Nevirapine (View Usage). Patient had the following side effects: pre-eclampsia on Jul 30, 2010 from Additional patient health information: Female patient , 21 years of age, was diagnosed with prophylaxis, human immunodeficiency virus transmission and. Nevirapine dosage: 400 Mg. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6916417-7 | Stillbirth
Adverse event was reported on Jul 30, 2010 by a Female patient taking Nevirapine (View Usage) (Dosage: 400 Mg) was diagnosed with prophylaxis, human immunodeficiency virus transmission and. Location: , 26 years of age, After Nevirapine was administered, patient had the following side effects: stillbirth. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6916415-3 |
on Jul 30, 2010 Female patient from , 43 years of age, was diagnosed with prophylaxis, human immunodeficiency virus transmission and was treated with Nevirapine (View Usage). . Nevirapine dosage: 400 Mg. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6916414-1 |
on Jul 30, 2010 Female patient from , 29 years of age, was diagnosed with prophylaxis, human immunodeficiency virus transmission and was treated with Nevirapine (View Usage). . Nevirapine dosage: 400 Mg. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6916413-X | Pre-eclampsia
Patient was taking Nevirapine (View Usage). After Nevirapine was administered, patient had the following side effects: pre-eclampsia on Jul 30, 2010 from Additional patient health information: Female patient , 29 years of age, was diagnosed with prophylaxis, human immunodeficiency virus transmission and. Nevirapine dosage: 400 Mg. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6916412-8 | Neutropenia
Adverse event was reported on Jul 30, 2010 by a Female patient taking Nevirapine (View Usage) (Dosage: 400 Mg) was diagnosed with prophylaxis, human immunodeficiency virus transmission and. Location: , 37 years of age, Patient experienced the following unwanted or unexpected effects: neutropenia. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6916326-3 | Premature Labour, Stillbirth
on Jul 30, 2010 Female patient from , 34 years of age, was diagnosed with prophylaxis, human immunodeficiency virus transmission and was treated with Nevirapine (View Usage). Patient had the following side effects: premature labour, stillbirth. Nevirapine dosage: 400 Mg. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6915982-3 |
on Jul 30, 2010 Female patient from , 40 years of age, was diagnosed with prophylaxis, human immunodeficiency virus transmission and was treated with Nevirapine (View Usage). . Nevirapine dosage: 400 Mg. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6915980-X | Pre-eclampsia
Patient was taking Nevirapine (View Usage). Patient experienced the following unwanted or unexpected effects: pre-eclampsia on Jul 30, 2010 from Additional patient health information: Female patient , 38 years of age, was diagnosed with prophylaxis, human immunodeficiency virus transmission and. Nevirapine dosage: 400 Mg. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6915613-2 | White Blood Cell Count Decreased
Adverse event was reported on Jul 30, 2010 by a Female patient taking Nevirapine (View Usage) (Dosage: 400 Mg) was diagnosed with prophylaxis, human immunodeficiency virus transmission and. Location: , 29 years of age, Patient had the following side effects: white blood cell count decreased. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6915612-0 |
on Jul 30, 2010 Female patient from , 38 years of age, was diagnosed with prophylaxis, human immunodeficiency virus transmission and was treated with Nevirapine (View Usage). . Nevirapine dosage: 400 Mg. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6915601-6 | Hyponatraemia
on Jul 30, 2010 Female patient from , 25 years of age, was diagnosed with prophylaxis, human immunodeficiency virus transmission and was treated with Nevirapine (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia. Nevirapine dosage: 400 Mg. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6915600-4 | Gestational Diabetes
Patient was taking Nevirapine (View Usage). Patient had the following side effects: gestational diabetes on Jul 30, 2010 from Additional patient health information: Female patient , 37 years of age, was diagnosed with prophylaxis, human immunodeficiency virus transmission and. Nevirapine dosage: 200 Mg. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6915599-0 | Cholangitis, Cholelithiasis
Adverse event was reported on Jul 30, 2010 by a Female patient taking Nevirapine (View Usage) (Dosage: 400 Mg) was diagnosed with prophylaxis, human immunodeficiency virus transmission and. Location: , 32 years of age, After Nevirapine was administered, patient had the following side effects: cholangitis, cholelithiasis. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6915043-3 | Pre-eclampsia
on Jul 30, 2010 Female patient from , 27 years of age, was diagnosed with prophylaxis, human immunodeficiency virus transmission and was treated with Nevirapine (View Usage). Patient experienced the following unwanted or unexpected effects: pre-eclampsia. Nevirapine dosage: 400 Mg. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6915042-1 | Premature Labour, Stillbirth
on Jul 30, 2010 Female patient from , 27 years of age, was diagnosed with prophylaxis, human immunodeficiency virus transmission and was treated with Nevirapine (View Usage). Patient had the following side effects: premature labour, stillbirth. Nevirapine dosage: 400 Mg. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6915041-X | Stillbirth
Patient was taking Nevirapine (View Usage). After Nevirapine was administered, patient had the following side effects: stillbirth on Jul 30, 2010 from Additional patient health information: Female patient , 40 years of age, was diagnosed with prophylaxis, human immunodeficiency virus transmission and. Nevirapine dosage: 400 Mg. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6915040-8 | Pre-eclampsia
Adverse event was reported on Jul 30, 2010 by a Female patient taking Nevirapine (View Usage) (Dosage: 400 Mg) was diagnosed with prophylaxis, human immunodeficiency virus transmission and. Location: , 25 years of age, Patient experienced the following unwanted or unexpected effects: pre-eclampsia. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6914999-2 |
on Jul 30, 2010 Female patient from , 31 years of age, was diagnosed with prophylaxis, human immunodeficiency virus transmission and was treated with Nevirapine (View Usage). . Nevirapine dosage: 400 Mg. During the same period patient was treated with COMBIVIR (600 Mg Of Zidovudine, And 300 Mg Of Lamivudine) (View Combivir Review and Combivir Label ).

6884100-2 | Hepatitis Cholestatic, Jaundice, Pruritus, Vanishing Bile Duct Syndrome
on Jul 19, 2010 Female patient from , 28 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Nevirapine (View Usage). After Nevirapine was administered, patient had the following side effects: hepatitis cholestatic, jaundice (What is jaundice?), pruritus, vanishing bile duct syndrome. Nevirapine dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ).

6767632-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Dyslipidaemia, Hepatic Enzyme Increased, Insulin Resistance, Oesophageal Varices Haemorrhage, Portal Hypertension
Patient was taking Nevirapine (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, dyslipidaemia, hepatic enzyme increased, insulin resistance, oesophageal varices haemorrhage, portal hypertension on Jun 04, 2010 from Additional patient health information: Male patient , 54 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Nevirapine dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), ABACAVIR (View Abacavir Review and Abacavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ).

6719369-8 | Narcotic Intoxication
Adverse event was reported on Apr 30, 2010 by a Male patient taking Nevirapine (View Usage) (Dosage: ) . Location: , 45 years of age, Patient had the following side effects: narcotic intoxication.

6630898-8 | Hepatotoxicity, Rash
on Feb 25, 2010 Female patient from , 34 years of age, was diagnosed with hiv infection (What is hiv infection?), tuberculosis (What is tuberculosis?) and was treated with Nevirapine (View Usage). After Nevirapine was administered, patient had the following side effects: hepatotoxicity, rash (What is rash?). Nevirapine dosage: 200 Mg. During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ANTI HIV AGENTS (View Anti-hiv Agents Review and Anti-hiv Agents Label ).

6630851-4 | Hepatotoxicity
on Feb 25, 2010 Female patient from , 48 years of age, was diagnosed with hiv infection (What is hiv infection?), tuberculosis (What is tuberculosis?) and was treated with Nevirapine (View Usage). Patient experienced the following unwanted or unexpected effects: hepatotoxicity. Nevirapine dosage: 200 Mg. During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ANTI HIV AGENTS (View Anti-hiv Agents Review and Anti-hiv Agents Label ).

6630313-4 | Hepatotoxicity, Rash
Patient was taking Nevirapine (View Usage). Patient had the following side effects: hepatotoxicity, rash (What is rash?) on Feb 25, 2010 from Additional patient health information: Female patient , 50 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Nevirapine dosage: 200 Mg. During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ANTI HIV AGENTS (View Anti-hiv Agents Review and Anti-hiv Agents Label ).

6603230-3 | Pneumonia
Adverse event was reported on Feb 19, 2010 by a Female patient taking Nevirapine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: , 31 years of age, After Nevirapine was administered, patient had the following side effects: pneumonia (What is pneumonia?). During the same period patient was treated with METHADONE HCL (80 Mg) (View Methadone Hcl Review and Methadone Hcl Label ). Patient was hospitalized.

6592630-6 | Deep Vein Thrombosis
on Feb 08, 2010 Female patient from FRANCE , 62 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Nevirapine (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?). Nevirapine dosage: 400 Mg, Unk. During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), FLUINDIONE (40 Mg, Unk) (View Fluindione Review and Fluindione Label ), WARFARIN SODIUM (6 Mg, Unk) (View Warfarin Sodium Review and Warfarin Sodium Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), RILMENIDINE (View Rilmenidine Review and Rilmenidine Label ).

6570377-X | Disseminated Tuberculosis, Histiocytosis Haematophagic, Immune Reconstitution Syndrome, Pancytopenia, Pyrexia, Weight Decreased
on Jan 27, 2010 Male patient from , 59 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Nevirapine (View Usage). Patient had the following side effects: disseminated tuberculosis, histiocytosis haematophagic, immune reconstitution syndrome, pancytopenia, pyrexia, weight decreased. Nevirapine dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ).

6570375-6 | Abdominal Wall Haematoma, Anaemia, Anti Factor Viii Antibody Positive, Coagulopathy, Ecchymosis, Haematuria, Muscle Haemorrhage
Patient was taking Nevirapine (View Usage). After Nevirapine was administered, patient had the following side effects: abdominal wall haematoma, anaemia, anti factor viii antibody positive, coagulopathy, ecchymosis, haematuria, muscle haemorrhage on Jan 28, 2010 from Additional patient health information: Male patient , 65 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Nevirapine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ). Patient was hospitalized.

6540378-6 | Diarrhoea, Haemorrhage, Hepatitis, Peritonitis, Stomatitis
Adverse event was reported on Jan 11, 2010 by a Female patient taking Nevirapine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: , 49 years of age, Patient experienced the following unwanted or unexpected effects: diarrhoea, haemorrhage, hepatitis (What is hepatitis?), peritonitis, stomatitis. During the same period patient was treated with ABACAVIR (View Abacavir Review and Abacavir Label ), LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ).

6536732-9 | Gastrointestinal Haemorrhage, Neonatal Respiratory Distress Syndrome, Pneumonia, Restlessness, Sepsis
on Jan 11, 2010 Female patient from , weighting 14.55 lb, was diagnosed with prophylaxis against hiv infection (What is prophylaxis against hiv infection?) and was treated with Nevirapine (View Usage). Patient had the following side effects: gastrointestinal haemorrhage, neonatal respiratory distress syndrome, pneumonia (What is pneumonia?), restlessness, sepsis (What is sepsis?). Nevirapine dosage: 2.8 Ml. During the same period patient was treated with AZT (View Azt Review and Azt Label ). Patient was hospitalized.

6517902-2 | Premature Baby
on Dec 10, 2009 Male patient from , weighting 6.17 lb, was treated with Nevirapine (View Usage). After Nevirapine was administered, patient had the following side effects: premature baby. Nevirapine dosage: . During the same period patient was treated with SEPTRIN (View Septrin Review and Septrin Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), ANALGESICS (View Analgesics Review and Analgesics Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ).

6517050-1 | Dermatitis Exfoliative, Dry Eye, Hypoxia, Keratitis, Purulent Discharge, Stevens-johnson Syndrome, Symblepharon, Tachycardia
Patient was taking Nevirapine (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative, dry eye, hypoxia, keratitis, purulent discharge, stevens-johnson syndrome, symblepharon, tachycardia on Dec 10, 2009 from Additional patient health information: Female patient , 27 years of age, was diagnosed with hiv infection (What is hiv infection?), prophylaxis and. Nevirapine dosage: . During the same period patient was treated with SEPTRIN (View Septrin Review and Septrin Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized.

6480800-7 | Immune Reconstitution Syndrome, Muscular Weakness, Paraesthesia
Adverse event was reported on Nov 24, 2009 by a Male patient taking Nevirapine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: , 47 years of age, Patient had the following side effects: immune reconstitution syndrome, muscular weakness, paraesthesia. During the same period patient was treated with ABACAVIR (View Abacavir Review and Abacavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6478861-4 | Altered State Of Consciousness, Immune Reconstitution Syndrome, Muscular Weakness
on Nov 24, 2009 Female patient from , 35 years of age, was diagnosed with hiv test positive (What is hiv test positive?) and was treated with Nevirapine (View Usage). After Nevirapine was administered, patient had the following side effects: altered state of consciousness, immune reconstitution syndrome, muscular weakness. Nevirapine dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ).

6390129-3 | Hypoxia, Immune Reconstitution Syndrome, Pneumocystis Jiroveci Infection
on Sep 24, 2009 Male patient from , 49 years of age, was diagnosed with hiv infection (What is hiv infection?), pneumocystis jiroveci pneumonia, antifungal prophylaxis and was treated with Nevirapine (View Usage). Patient experienced the following unwanted or unexpected effects: hypoxia, immune reconstitution syndrome, pneumocystis jiroveci infection. Nevirapine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), TRIMETHOPRIM + SULFAMETHOXAZOLE (18 Mg/kg/day Trimethoprim) (View Trimethoprim + Sulfamethoxazole Review and Trimethoprim + Sulfamethoxazole Label ).

6348003-4 | Dyspnoea, Immune Reconstitution Syndrome, Organising Pneumonia, Pneumocystis Jiroveci Pneumonia, Pyrexia
Patient was taking Nevirapine (View Usage). Patient had the following side effects: dyspnoea, immune reconstitution syndrome, organising pneumonia, pneumocystis jiroveci pneumonia, pyrexia on Sep 03, 2009 from Additional patient health information: Female patient , 54 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Nevirapine dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), ATAZANAVIR (View Atazanavir Review and Atazanavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ). Patient was hospitalized.